Zobrazeno 1 - 10
of 21
pro vyhledávání: ''
Autor:
Juan Carlos Cámara, Ana Leon, D. Marrupe, J. I. Martín-Valadés, Ana Royuela, Ana López-Alfonso, Mar Perez, Brezo Martinez-Amores, Ana Ruiz-Casado, D. Gutiérrez-Abad, Fábio Gazelato de Mello Franco, Ignacio Juez
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(4)
The incidence of pancreatic cancer is increasing in developed countries. The incorporation of new therapies, to the first-line treatment of patients with good performance status led to better survival in clinical trials. However, there is a wide vari
Autor:
Lize Wang, Ying-jian He, Tianmiao Wang, Yan-Ling Li, Jingjian Li, Z. Fan, T Ouyang, Yan-Di Xie
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(2)
To assess the performance of computed tomography (CT) reconstruction in evaluating the response in metastatic lymph nodes after neoadjuvant chemotherapy (NAC) in breast cancer patients. Patients undergoing pre-NAC and post-NAC CT were identified from
Autor:
Salvador Fernández-Arroyo, Y Murria, Meritxell Arenas, Jorge Joven, Marina Gascón, M. Mele, Kepa Amillano, Sebastià Sabater, Jordi Camps, Elisabet Rodríguez-Tomàs
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(7)
Neoadjuvant chemotherapy (NACT) is employed in patients with breast cancer (BC) with the aim of reducing tumor burden and improving surgical outcomes. We evaluated the levels of energy metabolites pre- and post-radiotherapy (RT) in breast cancer (BC)
Autor:
A. Del Conte, Fabrizio Tabbò, Emilio Bria, Sara Pilotto, Evaristo Maiello, Domenico Galetta, F.L. Cecere, Rita Chiari, Concetta Sergi, Frederico Cappuzzo, P. Pizzutillo, F. Riccardi, Marcello Tiseo, G. Borra, Vieri Scotti, Paola Bordi, Olga Martelli, Claudia Bareggi, Giulio Rossi, L. Ghilardi, Paolo Graziano, C. Casartelli, Elisa Gobbini, P. Rizzo, Antonio Rossi, M. Di Maio, Vanesa Gregorc, Angelo Delmonte, G. Osman, Diego Cortinovis, Silvia Novello
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(3)
Anaplastic lymphoma kinase (ALK) rearrangement confers sensitivity to ALK inhibitors (ALKis) in non-small-cell lung cancer (NSCLC). Although several drugs provided an impressive outcome benefit, the most effective sequential strategy is still unknown
Autor:
A, Viúdez, A, Carmona-Bayonas, J, Gallego, A, Lacalle, R, Hernández, J M, Cano, I, Macías, A, Custodio, E, Martínez de Castro, A, Sánchez, L, Iglesia, P, Reguera, L, Visa, A, Azkarate, M, Sánchez-Cánovas, M, Mangas, M L, Limón, A, Martínez-Torrón, E, Asensio, A, Ramchandani, A, Martín-Carnicero, A, Hurtado, P, Cerdà, M, Garrido, R, Sánchez-Bayonas, R, Serrano, P, Jiménez-Fonseca, Aitziber Gil-Negrete, Laborda
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Background The optimal duration of first-line chemotherapy for patients with advanced gastric cancer is unknown. Diverse clinical trials have proposed different strategies including limited treatment, maintenance of some drugs, or treatment until pro
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(5)
Patients with diagnosis of diffuse large B-cell lymphoma, who relapse after stem cell transplant (SCT) or are no candidates to SCT, have a poor prognosis and no current treatment is available. Thus, we conduct a rotatory chemotherapy schedule that em
Autor:
Tina Sidoni, Alessio Cortellini, Corrado Ficorella, Alessandro Parisi, Katia Cannita, V. Cocciolone, G. Porzio, P. Lanfiuti Baldi, E. Palluzzi
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(1)
One of the major challenges related to solvent-based taxanes administration in clinical practice is the high rate of hypersensitivity reactions (HSRs). Nab-paclitaxel is a solvent-free, albumin-bound, paclitaxel, which minimize the risk of HSR occurr
Autor:
Qianqian Xiong, Xiaosheng Zhuang, Zhenyu Liu, Teng Zhu, Changhong Liang, Jie Tian, Liulu Zhang, Zaiyi Liu, Chuqian Lei, Kun Wang, Mei Yang, Ci-Qiu Yang, Xuezhi Zhou
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(1)
To evaluate the value of multiparametric magnetic resonance imaging (MRI) in pretreatment prediction of breast cancers insensitive to neoadjuvant chemotherapy (NAC). A total of 125 breast cancer patients (63 in the primary cohort and 62 in the valida
Autor:
Feng Wen, Pengfei Zhang, Xinyuan Wang, Kexun Zhou, Jiaxing Huang, Jian Zhou, Weiting Liao, Qiuji Wu, Mengxi Zhang, Qianrui Li
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(1)
The aim of the study was to evaluate the cost-effectiveness of capecitabine plus bevacizumab compared with capecitabine alone in elderly patients with metastatic colorectal cancer (CRC) from a Chinese societal perspective. A decision-analytic Markov
Autor:
Jean-François Honart, A. Hadiji, Charles Honoré, A. Le Cesne, C. Lepechoux, Tony Ibrahim, Philippe Terrier, Olivier Camuzard, Andrea Cavalcanti, Matthieu Faron, Tarek Assi, Sarah Dumont, Olivier Mir, Julien Adam
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 21(9)
Limb-sparing surgery in locally advanced soft tissue sarcomas (LA STS) is challenging. The aim of this study is to evaluate upfront isolated limb perfusion (ILP) in untreated patients with LA STS. All consecutive patients with LA STS of the limbs dee